Millennium Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-139
| Closed | -$2.91K | – | 4144 |
|
|
2025
Q1 | $2.91K | Sell |
139
-5
| -3% | -$105 | ﹤0.01% | 3911 |
|
|
2024
Q4 | $3.59K | Sell |
144
-45
| -24% | -$1.12K | ﹤0.01% | 4020 |
|
|
2024
Q3 | $3.19K | Sell |
189
-1,673
| -90% | -$28.2K | ﹤0.01% | 4038 |
|
|
2024
Q2 | $52.4K | Sell |
1,862
-5,608
| -75% | -$158K | ﹤0.01% | 3779 |
|
|
2024
Q1 | $2.24M | Buy |
7,470
+7,081
| +1,820% | +$2.12M | ﹤0.01% | 2506 |
|
|
2023
Q4 | $91.8K | Sell |
389
-250
| -39% | -$59K | ﹤0.01% | 3715 |
|
|
2023
Q3 | $95.8K | Sell |
639
-139
| -18% | -$20.8K | ﹤0.01% | 3784 |
|
|
2023
Q2 | $135K | Sell |
778
-4,120
| -84% | -$717K | ﹤0.01% | 3812 |
|
|
2023
Q1 | $617K | Sell |
4,898
-4,331
| -47% | -$546K | ﹤0.01% | 3328 |
|
|
2022
Q4 | $2.8M | Buy |
9,229
+5,566
| +152% | +$1.69M | ﹤0.01% | 2485 |
|
|
2022
Q3 | $202K | Sell |
3,663
-684
| -16% | -$37.7K | ﹤0.01% | 4435 |
|
|
2022
Q2 | $260K | Buy |
4,347
+305
| +8% | +$18.2K | ﹤0.01% | 4324 |
|
|
2022
Q1 | $461K | Sell |
4,042
-2,875
| -42% | -$328K | ﹤0.01% | 4135 |
|
|
2021
Q4 | $996K | Buy |
6,917
+2,437
| +54% | +$351K | ﹤0.01% | 3495 |
|
|
2021
Q3 | $981K | Sell |
4,480
-2,386
| -35% | -$522K | ﹤0.01% | 3671 |
|
|
2021
Q2 | $1.59M | Buy |
6,866
+6,370
| +1,284% | +$1.48M | ﹤0.01% | 3348 |
|
|
2021
Q1 | $149K | Sell |
496
-1,729
| -78% | -$519K | ﹤0.01% | 4230 |
|
|
2020
Q4 | $837K | Buy |
+2,225
| New | +$837K | ﹤0.01% | 2974 |
|
|
2020
Q3 | – | Sell |
-1,318
| Closed | -$496K | – | 3708 |
|
|
2020
Q2 | $496K | Buy |
1,318
+260
| +25% | +$97.8K | ﹤0.01% | 2741 |
|
|
2020
Q1 | $241K | Buy |
1,058
+276
| +35% | +$62.9K | ﹤0.01% | 2651 |
|
|
2019
Q4 | $414K | Sell |
782
-1,532
| -66% | -$811K | ﹤0.01% | 2843 |
|
|
2019
Q3 | $997K | Buy |
2,314
+1,978
| +589% | +$852K | ﹤0.01% | 2338 |
|
|
2019
Q2 | $400K | Buy |
336
+153
| +84% | +$182K | ﹤0.01% | 2867 |
|
|
2019
Q1 | $228K | Sell |
183
-51
| -22% | -$63.5K | ﹤0.01% | 3144 |
|
|
2018
Q4 | $222K | Buy |
+234
| New | +$222K | ﹤0.01% | 2975 |
|
|
2018
Q3 | – | Sell |
-1,312
| Closed | -$2.12M | – | 3603 |
|
|
2018
Q2 | $2.12M | Sell |
1,312
-1,054
| -45% | -$1.7M | ﹤0.01% | 2082 |
|
|
2018
Q1 | $3.84M | Buy |
2,366
+2,234
| +1,692% | +$3.63M | 0.01% | 1831 |
|
|
2017
Q4 | $221K | Sell |
132
-6,718
| -98% | -$11.2M | ﹤0.01% | 3254 |
|
|
2017
Q3 | $9.58M | Sell |
6,850
-6,919
| -50% | -$9.68M | 0.01% | 1198 |
|
|
2017
Q2 | $15.4M | Buy |
13,769
+13,331
| +3,044% | +$14.9M | 0.03% | 752 |
|
|
2017
Q1 | $238K | Sell |
438
-70
| -14% | -$38K | ﹤0.01% | 2908 |
|
|
2016
Q4 | $310K | Buy |
+508
| New | +$310K | ﹤0.01% | 2668 |
|
|
2014
Q3 | – | Sell |
-136
| Closed | -$115K | – | 2971 |
|
|
2014
Q2 | $115K | Buy |
+136
| New | +$115K | ﹤0.01% | 2672 |
|